Predictive and prognostic markers of endometrial cancer

被引：0

作者：

Steiner, E. ^{[1
]}

Einenkel, J. ^{[2
]}

Schmidt, D. ^{[3
]}

Horn, L. -C. ^{[4
]}

机构：

[1] Frauenklin GPR Klinikum, D-65428 Russelsheim, Germany

[2] Univ Leipzig, Univ Frauenklin Leipzig, Triersches Inst, Abt Gynakol Onkol,Zentrum Frauen & Kindermed, Leipzig, Germany

[3] Inst Pathol Mannheim, Mannheim, Germany

[4] Univ Leipzig, Inst Pathol, Zentrum Diagnost, Abt Mamma Gynako & Perinatalpathol, Leipzig, Germany

来源：

ONKOLOGE | 2012年 / 18卷 / 10期

关键词：

Endometrial cancer; Biomarkers; Tumor type; Histopathology; Gene expression; GYNECOLOGIC-ONCOLOGY-GROUP; CLINICAL STAGE-I; PAPILLARY-SEROUS-CARCINOMA; LYMPHVASCULAR SPACE INVOLVEMENT; POSITIVE PERITONEAL CYTOLOGY; CLEAR-CELL CARCINOMA; GRADING SYSTEMS; CERVICAL INVOLVEMENT; MYOMETRIAL INVASION; DISTANT FAILURE;

D O I：

10.1007/s00761-012-2289-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Within the last years a reliable number of studies have analysed predictive and prognostic factors fort the definition of biologically similar subgroups, testing treatment results and for the definition of tailored therapy approaches in patients affected by endometrial cancer (EC). Several studies have demonstrated the prognostic and therapeutic impact of lymph node status, histological tumor type (type 1 vs. type 2 cancers), histological grade, stage of disease, depth of myometrial invasion, lymphovascular space involvement and cervical involvement. Understanding pathogenesis at the molecular level is essential in identifying biomarkers for successful targeted therapies. New parameters and gene expression analysis are identifying different types of endometrial cancer with different prognoses, but theses data are still provisory.

引用

页码：853 / +

页数：8

共 98 条

[1] ABELER VM, 1991, CANCER, V67, P3093, DOI 10.1002/1097-0142(19910615)67:12<3093::AID-CNCR2820671226>3.0.CO
[2] 2-L
[3] Rare uterine cancers
Acharya, S
Hensley, ML
Montag, AC
Fleming, GF
[J]. LANCET ONCOLOGY, 2005, 6 (12) : 961 - 971
[4] Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems
Alkushi, A
Abdul-Rahman, ZH
Lim, P
Schulzer, M
Coldman, A
Kalloger, SE
Miller, D
Gilks, CB
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (03) : 295 - 304
[5] High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and Outcomes
Alkushi, Abdulmohsen
Koebel, Martin
Kalloger, Steve E.
Gilks, C. Blake
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2010, 29 (04) : 343 - 350
[6] [Anonymous], 2003, TUMOURS BREAST FEMAL
[7] Outcome of endometrial carcinoma patients with involvement of the uterine serosa
Ashman, JB
Connell, PP
Yamada, D
Rotmensch, J
Waggoner, SE
Mundt, AJ
[J]. GYNECOLOGIC ONCOLOGY, 2001, 82 (02) : 338 - 343
[8] Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer
Baldinu, P
Cossu, A
Manca, A
Satta, MP
Sini, MC
Rozzo, C
Dessole, S
Cherchi, P
Gianfrancesco, F
Pintus, A
Carboni, A
Deiana, A
Tanda, F
Palmieri, G
[J]. HUMAN MUTATION, 2004, 23 (04) : 318 - 326
[9] Endometrial Carcinomas: A Review Emphasizing Overlapping and Distinctive Morphological and Immunohistochemical Features
Bartosch, Carla
Lopes, Jose Manuel
Oliva, Esther
[J]. ADVANCES IN ANATOMIC PATHOLOGY, 2011, 18 (06) : 415 - 437
[10] 2 PATHOGENETIC TYPES OF ENDOMETRIAL CARCINOMA
BOKHMAN, JV
[J]. GYNECOLOGIC ONCOLOGY, 1983, 15 (01) : 10 - 17

← 1 2 3 4 5 6 7 8 9 10 →